In humans, Cariou et al. [8] did not find any variation in PCSK9 levels after a fat load in healthy individuals, while Chan et al. [9] concluded that catabolism of triglycerides and apoB-48-containing chylomicrons may be regulated by PCSK-9 in individuals with obesity. This evidence concerns the gene PCSK9 and obesity disorder.